Market Research Logo

HIV Pipeline Highlights – 2017 Update

HIV Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, HIV Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global HIV market. It covers emerging therapies for HIV in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides HIV pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides HIV pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides HIV pipeline products by the company.

Short-term Launch Highlights:
Find out which HIV pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • HIV phase 3 clinical trial pipeline products
  • HIV phase 2 clinical trial pipeline products
  • HIV phase 1 clinical trial pipeline products
  • HIV preclinical research pipeline products
  • HIV discovery stage pipeline products
  • HIV pipeline products short-term launch highlights


1. HIV Pipeline by Stages
2. HIV Pipeline by Drug Class
3. HIV Pipeline by Company
4. HIV Phase 3 Clinical Trial Insights
5. HIV Phase 2 Clinical Trial Insights
6. HIV Phase 1 Clinical Trial Insights
7. HIV Preclinical Research Insights
8. HIV Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: HIV Phase 3 Clinical Trials, 2017
Table 2: HIV Phase 2 Clinical Trials, 2017
Table 3: HIV Phase 1 Clinical Trials, 2017
Table 4: HIV Preclinical Research, 2017
Table 5: HIV Discovery Stage, 2017
LIST OF FIGURES
Figure 1: HIV Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: HIV Pipeline Molecules by Drug Class, 2017
Figure 3: HIV Pipeline Molecules by Company, 2017
Figure 4: HIV Phase 3 Clinical Trial Highlights, 2017
Figure 5: HIV Phase 2 Clinical Trial Highlights, 2017
Figure 6: HIV Phase 1 Clinical Trial Highlights, 2017
Figure 7: HIV Preclinical Research Highlights, 2017
Figure 8: HIV Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report